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Abstract
Background: Reactive astrogliosis is a remarkable pathogenetic hallmark of the brains of Parkinson’s disease (PD)
patients, but its progressive fate and regulation mechanisms are poorly understood. In this study, growth arrest
specific 1 (Gas1), a tumor growth suppressor oncogene, was identified as a novel modulator of the cell apoptosis
of reactive astrocytes in primary culture and the injured substantia nigra.
Methods: Animal models and cell cultures were utilized in the present study. Lipopolysaccharide (LPS)- and
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated animal models were used to detect Gas1 expression
in the brain via immunohistochemistry and western blot. Cell cultures were performed to analyze Gas1 functions
in the viability and apoptosis of reactive astrocytes and SH-SY5Y cells by double labeling, CCK-8, LDH, TUNEL, flow
cytometry, and siRNA knockdown methods.
Results: Gas1 expressions were significantly elevated in the majority of the reactive astrocytes of the brains with
LPS or MPTP insults. In the injured substantia nigras, GFAP-positive astrocytes exhibited higher levels of cleaved
caspase-3. In cell culture, the up-regulated Gas1 expression induced apoptosis of reactive astrocytes that were
insulted by LPS in combination with interferon-γ and tumor necrosis factor-a. This effect was confirmed through
siRNA knockdown of Gas1 gene expression. Finally and interestingly, the potential underlying signaling pathways
were evidently related to an increase in the Bax/Bcl-2 ratio, the abundant generation of reactive oxygen species
and the activation of cleaved caspase-3.
Conclusions: This study demonstrated that the up-regulation of inducible Gas1 contributed to the apoptosis of
reactive astrocytes in the injured nigra. Gas1 signaling may function as a novel regulator of astrogliosis and is
thus a potential intervention target for inflammatory events in PD conditions.
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Background
Parkinson’s disease (PD) is one of the most common
neurodegenerative diseases in human beings and is
characterized by the progressive loss of dopaminergic
neurons in the substantia nigra (SN) and axonal termi-
nals in the striatum. Despite previous intensive studies,
the mechanisms underlying the degeneration of dopami-
nergic neurons remain poorly understood. Many studies
have demonstrated that neuroinflammation mediated
by astrocytes and microglial cells may play a vital role
in the death or survival of nigral dopaminergic neurons
[1]. Astrocytes, i.e., the most abundant glial cell type in
the central nervous system (CNS), can provide essential
support for the homeostasis of various CNS neurons,
e.g., the supplementation of energy substances and
growth factors, the regulation of blood flow, and active
participation in synaptic transmission and plasticity [2].
However, in the pathogenesis and progression of PD,
astrocytes undergo hypertrophy, proliferation, and dy-
namic changes in the expression of genes such as glial
fibrillary acidic protein (GFAP) and vimentin, and this
process is referred to as astrogliosis [3]. Accumulating
evidence suggests that these activated astrocytes produce
diverse inflammatory factors, such as pro-inflammatory
cytokines and nitric oxide (NO) [4, 5], which then contri-
bute to the neurotoxicity of the surrounding dopaminergic
neurons. Apparently, the proper regulation of astrocyte-
mediated neuroinflammation is essential for the preven-
tion of the progression of PD [6]. One possible method to
eliminate the overactivation of astrocytes is the limitation
of astrogliosis strength in the inflammatory response.
Interestingly, cell apoptosis among the activated astrocytes
has been noted in vivo in the brains of Alzheimer’s disease
[7] and HIV encephalitis [8] patients. In vitro, astrocytes
also undergo apoptosis following strong activation by
lipopolysaccharide (LPS) and other inflammatory stimuli
[9, 10]. There is a growing consensus that the apoptosis
of activated astrocytes may present as a self-regulatory
mechanism to control the severity of inflammation in the
brain [11]. However, currently, the molecular mechanisms
underlying this self-regulation of the apoptosis of astro-
cytes are still far from clear.
Growth arrest specific 1 (Gas1) is a glycosylphosphatidyl
inositol (GPI)-linked protein and a pleiotropic protein
found in various cell types. Initially, Gas1 was found to
block the cell cycle in the transition from the G0 phase to
the S phase when a cell culture was deprived of serum or
in a confluent state [12]. Subsequently, Gas1 was reported
to be capable of inducing apoptosis in different cells, such
as gliomas, gastric cancer, and even hippocampal neural
cells [13–16]. For mechanical signaling studies, the PI3
kinase and NFkB signaling pathways were proposed to
participate in the induction of Gas1 expression in endo-
thelial cells [17]. Additionally, sonic hedgehog signaling is
also involved in Gas1 regulation in mammalian embryonic
development [18]. Recent studies have confirmed that
Gas1 is widely expressed in neurons and astrocytes in the
adult CNS [19]. While the engagement of Gas1 in neu-
ronal apoptosis has been observed in SH-SY5Y cells and
the hippocampus [15, 16], its potential role in the regula-
tion of astrocytes has yet to be determined. Therefore, in
the present study, we focused on the critical role of Gas1
in the self-regulatory apoptosis of activated astrocytes and
identified Gas1 as a novel modulator of reactive astrocytes
in an animal model of PD and cell culture. The data from
this study suggest that Gas1 actively works in cell apop-
tosis in reactive astrocytes in the manners of increasing
reactive oxygen species generation, the Bax/Bcl-2 ratio,
and caspase-3 activation during the neuroinflammatory
response.
Methods
Preparation of the LPS rat model and the MPTP mouse
model
Sprague-Dawley rats and C57BL/6 mice were used in
this study and were supplied from the Animal Center of
the Fourth Military Medical University (FMMU), China.
All animal experiments were performed in accordance
with the National Institutes of Health guide for the care
and use of Laboratory animals (NIH Publications No.
80-23), revised 1996, and approved by the Committee of
Animal Use for Research and Education of FMMU. All
efforts were made to minimize animal suffering and re-
duce the numbers of animals used.
For the preparation of the LPS rat model and the
MPTP mouse model, the treatments of the animals were
performed as described in our previous studies [20].
Briefly, adult rats received unilateral injections of LPS
(Sigma, L6143, 0.5 μl of 10 μg/μl diluted in 0.9 % saline)
into the medial forebrain bundle (MFB) at the following
coordinates, AP −4.2 mm, L 1.5 mm, and V 7.8 mm,
and into the contralateral side with the same volume of
0.9 % saline. Adult mice were administered intraperito-
neal injections of MPTP (Sigma, M0896) of 25 mg/kg
per day for five continuous days, and the same volume
of saline was injected as a control. All the animals were
sacrificed at week 1, 2, 3, or 4 after the LPS or MPTP injec-
tions. The brain samples were collected for the subsequent
immunohistochemistry and western blot experiments.
Cell cultures of the primary astrocytes and SH-SY5Y cells
The primary astrocytes were isolated from the cortex,
striatum, or ventral midbrain of 1–3-day-old neonatal
rats as described previously [20]. The dissociated cells
were seeded and cultured in 75-cm2 flasks coated with
poly-L-lysine in Dulbecco’s modified Eagle’s medium-
high glucose (DMEM-HG) supplemented with 10 % fetal
calf serum and 100 U/ml penicillin/streptomycin in
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humidified 5 % CO2 and 95 % air at 37 °C. When the
cells grew to confluence, the flasks were shaken at
280 rpm for approximately 20 h at 37 °C. Immuno-
cytochemistry was performed to guarantee that the per-
centage of GFAP-positive cells was >95 %. Additionally,
the SH-SY5Y cells were also cultured under the same
conditions employed for the primary astrocytes.
The astrocytes and SH-SY5Y cells were plated in 60-mm
dishes with serum-containing media. After the concen-
trations reached 80 % confluence, the culture media of
the astrocytes were replaced with serum-free media
with different LPS (Sigma, L6143) and cytokine (IFNγ
50 ng/ml, TNFα 10 ng/ml) concentrations alone or in
combination for the indicated times. For the induce-
ment of Gas1 expression, the media of the SH-SY5Y
cells were replaced with serum-free media and cultured
for different time periods.
Transfection of Gas1 siRNA in the cultured primary
astrocytes
The knock-down of the Gas1 gene (GenBank accession
number NC_005116) expression was performed. For the
transfection of the siRNAs, the rat primary astrocytes
were seeded in 6-well or 96-well dishes 24 h before
transfection with siRNAs targeting Gas1 or control
siRNA (Jima) using lipofectamine 2000 (Invitrogen) for
6 h basically according to the manufacturer’s instruc-
tions. siRNA duplexes were prepared as follows: sense:
5′-CUACUACGACGAAGAAUAUTT-3′; and antisense:
5′-AUAUUCUUCGUCGUAGUAGTT-3′. At 48 h after
siRNA transfection, the astrocytes were treated with
LPS, IFNγ, and TNFα for 24 h and then collected for the
following western blot or real-time PCR analyses.
CCK-8 assay and LDH release assay
After the astrocytes were treated with different reagents,
the cell viabilities were assessed using the CCK-8 assay
according to the manufacturer’s instructions (Nanjing
Vazyme Biotech Co.). The lactate dehydrogenase (LDH)
release was also assessed to indicate the injury to the
astrocytes, using a commercial kit (Beyotime Biotech-
nology). For the CCK-8 assay, the final data were pre-
sented as the percentages of the control levels. For the
LDH release measurements, the final data are presented
as the percentages of the maximal values.
Flow cytometry assay
Flow cytometry analyses were also used to quantify the
survival, necrosis, and apoptosis of the primary astro-
cytes. The cultured astrocytes were harvested, and flow
cytometry assays were performed via Annexin V-PI
staining. The cell survivals, necrosis, early apoptosis, and
later apoptosis are, respectively, illustrated via percen-
tages and dot images.
Quantitative detection of the reactive oxygen species
Intracellular reactive oxygen species (ROS) was mea-
sured using the DCFH-DA fluorescent probe (Beyotime
Biotechnology) according to the manufacturer’s ins-
tructions. Briefly, the primary astrocytes were seeded in
96-well plates and processed for treatments with different
reagents for 24 h. Next, the culture media were removed,
and 10 μM DCFH-DA was added to the cultures and
incubated at 37 °C for 30 min. After washing thrice in
PBS, the fluorescence intensities were measured on a
microplate reader with a 485-nm excitation wavelength
and a 35-nm emission wavelength.
BrdU incorporation and TUNEL assay
The BrdU incorporation and TUNEL assays were further
performed as previously described [21]. Briefly, to mea-
sure the proliferation activity, the cultured astrocytes
were incubated with 10 μM bromodeoxyuridine (BrdU,
Sigma) for 30 min. After fixation with 4 % PFA, the cells
were incubated with 2 N HCl for 40 min at 37 °C and
subsequently neutralized with 0.1 M borate buffer (pH
8.5) three times. After blocking with 1 % BSA for 1 h,
the cells were probed with FITC-conjugated anti-BrdU
antibody (Millipore, 1:100). To detect apoptosis, ter-
minal deoxynucleotidyl transferase-dUTP nick end la-
beling (TUNEL) was performed with a commercial kit
(Roche). Immunostaining fluorescence was observed
under a laser scanning confocal microscope (LSCM,
FV1000, Olympus, Japan).
Immunohistochemistry and double immunofluorescence
For immunohistochemistry, the animals were perfused
transcardially with 4 % paraformaldehyde fixation and
sectioned for cryostat analyses. The midbrain sections
containing the nigra were incubated in the following pri-
mary antibodies: mouse anti-TH (Sigma, 1:3000), rabbit
anti-iba1 (Wako, 1:3000), mouse anti-GFAP (Millipore,
1:4000), rabbit anti-Gas1 (Santa Cruz, 1:100), rabbit anti-
cleaved caspase-3 (Cell Signaling Technology, 1:500), and
mouse anti-Ki-67 (Cell Signaling Technology, 1:700) in
0.01 M PBS containing 1 % bovine serum albumin and
0.1 % Triton X-100 for 24 h at 4 °C. After washing, the
sections were incubated with the corresponding Alexa
Fluo594-conjugated donkey anti-mouse and Alexa
Fluo488-conjugated anti-rabbit IgGs for 2 h at room
temperature. Immunostaining for the cultured astro-
cytes was also performed with a similar protocol. The
nigral sections and cultured cells were observed, and
the images of interest were captured under LSCM. For
the quantitative data collection, the numbers of immu-
nopositive cells were counted in every six sections
(30-μm thickness) of the substantia nigra or six repre-
sentative unit areas of cell cultures and averaged by
two blinded observers.
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Real-time PCR
The total RNA was isolated from the primary astrocytes
with Trizol reagent (Invitrogen) according to the manu-
facturer’s instructions. After reverse-transcription, the
real-time PCR was performed using SYBR Green PCR
Master Mix (TaKaRa). The primers for the rat Gas1 and






The protein extraction and western blot were performed
as described previously [20]. Fresh brain tissue or cul-
tured cells were collected, and cell lysates were prepared
in the lysis buffer (Beyotime Biotechnology). Next, after
separation in sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) gels (10 or 12 %), the
protein samples were transferred to PVDF membranes
(Millipore). The membranes were blocked with 5 % non-
fat milk/TBST (0.1 % Tween-20, TBS) for 1 h and incu-
bated with the following antibodies: rabbit anti-Gas1
(Santa Cruz), mouse anti-TH (Sigma), mouse anti-GFAP
(Millipore), rabbit anti-cleaved caspase-3 (Cell Signaling
Technology), rabbit anti-iNOS (Abcam), mouse anti-
p-NFkB-p65 (Sigma), rabbit anti-Bax (BBIAB, Sangon
Biotech), rabbit anti-Bcl-2 (Bioworld), and rabbit anti-
β-actin (Sigma) at 4 °C overnight, and β-actin was used
as the loading control for the immunoblotting. After
incubation with the appropriate HRP-conjugated secon-
dary antibodies at room temperature for 1 h, the immu-
noblot bands were detected using an advanced ECL
detection kit (Millipore). The immunoblots were digitally
acquired using the Bio-Rad System. The quantitative data
analyses of the immunoblots were performed and are
shown in the density ratios compared with those of the
control groups.
Statistical data analysis
All quantitative data were collected from at least three
animal samples or three independent experiments and
are presented as the means ± the S.E.Ms. The statistically
significant differences between groups or treatments were
determined by one-way analysis of variation (ANOVA)
with Student Newman-Keuls post hoc analyses. The level
of significance was set at P < 0.05 for all analyses.
Results
Cellular localization and Gas1 up-regulation in the nigral
astrocyte LPS rat model and MPTP mouse model
The reactive astrocytes in the substantia nigra of the PD
model were characterized with morphological changes in
their enhanced proliferation and expression of intermediate
filament GFAP [3]. The Gas1 expression profile of the
reactive astrocytes was first examined in the nigra of the
LPS rat model and MPTP mouse model, both of which
exhibited significant inflammatory responses. At 2, 3,
and 4 weeks after the stereotactic injection of LPS in
the nigra, the midbrain sections were doubly labeled
with Gas1/GFAP immunofluorescence. The Gas1 in the
GFAP-positive astrocytes was up-regulated and accom-
panied by remarkable astrogliosis in the substantia
nigra. Due to the host restriction of the antibodies for
double immunofluorescence, Gas1 and iba1 (a microglia
marker) were not doubly labeled. Gas1/GFAP-double
labeled astrocytes almost occupied all the shape of glial
cells, which indicated that microglia might not express
or express very lowly levels of Gas1 in the nigra (Fig. 1a,
Additional file 1: Figure S1A). The positive expression
of Gas1 was then confirmed in the reactive nigral astro-
cytes of the MPTP model (Fig. 2a). Additionally, Gas1-
immunoreactivity was also observed in numerous nigral
neurons indicated by Gas1/TH double immunofluores-
cence (Fig. 2a, Additional file 2: Figure S1B).
The tissue lysates dissected from the ventral midbrain
of the LPS rat model and the MPTP mouse model were
analyzed via western blotting. The significant increases
in the Gas1 expression level were detected after the LPS
and MPTP insults (Figs. 1b, c and 2b, c), which were ba-
sically consistent with double labeling. Regarding speci-
fically confirming the Gas1 antibody used, the cultured
SH-SY5Y cells were applied as a positive immunoblot
control (Additional file 1: Figure S2A, B) and had pre-
viously been reported to express Gas1 protein under a
serum-deprived state [15]. Moreover, the appearance
and molecular weight of the detected Gas1 immuno-
blot bands were also clearly consistent with previous
literature [22–24].
Apoptotic appearance of astrocytes accompanied with
Gas1 up-regulation in the injured nigra of the LPS and
MPTP models
Cleaved caspase-3-positive astrocytes were numerously
observed in the substantia nigra after the LPS insult, but
few were detected in the contralateral side at the same
time-point (Fig. 1d, e). Consistently, western blotting
revealed the significant expression of cleaved caspase-3
in the substantia nigra of the LPS model rats and the
MPTP model mice (Figs. 1b–e and 2b, c). Thus, these
findings indicated that the up-regulated Gas1 expression
was accompanied by an obvious activation of the caspase-
3-dependent pathway in the reactive astrocytes, which
suggested the enrolment of increased Gas1 signaling in
the apoptosis of these activated astrocytes in the injured
substantia nigra under the LPS and MPTP insults.
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At the same time, the nigral neurons in both the LPS
rat model and MPTP mouse model were confirmed
and the neuronal degeneration or injury of the nigral
TH-positive neurons were observed as reported in our
previous studies [20, 25]. Indeed, Gas1 expression was
clearly observed in both the nigral TH-positive dopa-
minergic neurons and the GFAP-positive reactive
astrocytes, and the possible implication of Gas1 up-
regulation in the mediation of neuronal apoptosis has
been evidenced in Gas1 functional studies in SH-SY5Y
cells under serum-deprived states and in also in the
hippocampus [15, 16].
Dynamic changes in Gas1 expression in primary
astrocytes in relation to cell density
In the cell culture, the influence of cell density on Gas1
expression in the primary astrocytes was analyzed because
Gas1 may be involved in the contact inhibition of cell
proliferation. Primary astrocytes were plated at a low cell
density in DMEM with 10 % FCS and cultured for 0, 24,
48, 72, and 96 h until they achieved confluences of up to
100 %. The levels of Gas1 and cleaved caspase-3 increased
gradually in the astrocytes at higher confluences (Fig. 3a).
To confirm whether this effect was consistent for astro-
cytes from different brain regions, astrocytes isolated from
Fig. 1 Induction of Gas1 expression and cleaved caspase-3 (CC-3) in the nigral astrocytes of LPS rat model. a Double labeling shows Gas1/GFAP-
positive astrocytes in the substantia nigra of control and LPS group and magnified in inserts. b Immunoblots of Gas1 and CC-3 in the ventral
midbrains of control and LPS-2-, 3-, and 4-week groups. c Comparison of Gas1 and CC-3 levels among above groups (density in ratios of
interested groups compared with control). d GFAP/CC-3 double labeling in the nigra of control and LPS group. e Comparison of GFAP/CC-3-positive
astrocytes between control and LPS group. ANOVA, *P < 0.05, **P < 0.01 vs control (mean ± S.E.M., n = 3)
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the cerebral cortex and nigra were plated at low (50 %)
and high (90 and 100 %) densities in DMEM with 10 %
FCS and lysed at the same time. The levels of Gas1 expres-
sion increased in the astrocytes from both brain regions at
the higher cell densities in similar patterns (Fig. 3b).
Cell viability was then measured in the astrocytes that
were insulted with LPS at different concentrations and
different treatment periods of 0–96 h. A CCK-8 assay
revealed that LPS alone had no significant effect on
the cell viabilities of the astrocytes after treatments
with various LPS concentrations (0–20 μg/ml) at the
time-points of 6, 12, 24, and 48 h. There were also no
detectable changes in cell viability in the LPS group
compared with the controls at the time-points of 0 to
96 h in the primary astrocytes (Fig. 3c, d).
Gas1 up-regulation, increased ROS generation, and
decreased cell viability of the astrocytes induced by
exposure to LPS, IFNγ, and TNFα
After excluding the direct cytotoxicity of the LPS expo-
sure of the primary astrocytes, we further examined the
effects of combinations of LPS and its induced products
IFNγ and TNFα from microglial cells or lymphocytes in
neuroinflammation events [26]. To demonstrate the in-
fluence of Gas1 changes on iNOS, ROS, cell viability,
and cell death, LPS, IFNγ, TNFα, and their combinations
were applied to cultured astrocytes (Fig. 4). The results
revealed that no significant changes were observed in
Gas1 expression, iNOS, ROS, cell viability, or death in
the controls. In the LPS + IFNγ + TNFα, LPS + IFNγ, and
IFNγ + TNFα groups, the up-regulation of Gas1 expres-
sion was significant and accompanied by an enhanced
iNOS level, increased ROS generation, decreased viability,
and increased death of the astrocytes (Fig. 4a–f ). In the
LPS, LPS + TNFα, and IFNγ groups, Gas1 expression
remained constant along with unchanged cell viability
and death, while increases in iNOS and ROS levels were
still observed. Unexpectedly, exposure to TNFα singly
did not result in obvious effects on Gas1, iNOS, ROS, cell
viability, or astrocyte death compared with the controls.
Furthermore, similar changes in viability were observed
in the astrocytes that were isolated from different brain
Fig. 2 Expression of Gas1 and cleaved caspase-3 (CC-3) in the nigral astrocytes and neurons of MPTP mouse model. a Double labeling shows
Gas1/GFAP-positive astrocytes and Gas1/TH-positive neurons in the substantia nigra of control and MPTP group and magnified in inserts.
b Immunoblots of GFAP, Gas1, and CC-3 in the ventral midbrains of control and MPTP model. c Comparison of GFAP, Gas1, and CC-3 expression
levels among control and MPTP group. ANOVA, *P < 0.05, **P < 0.01 vs control (mean ± S.E.M., n = 3)
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regions, i.e., the cerebral cortex, nigra, and striatum
(Additional file 2: Figure S2C, D). The data collectively
indicated that the up-regulation of the Gas1 expression
level was consistent with the decreased cell viability
and increased cell death of the primary astrocytes, and
it partially conformed to the increases in the levels of
iNOS and ROS generation. Thus, these findings also
suggested that the increases in iNOS and ROS generation
might have possibly contributed to the Gas1-induced
apoptosis of the reactive astrocytes following exposure to
certain inflammatory cytokines, most obviously after the
stimulation with the combination of LPS, IFNγ, and TNFα.
Decreased viability of astrocytes induced by LPS, IFNγ,
and TNFα via influences on cell apoptosis and cell
proliferation
To examine the possible reasons for the viability decreases
of the primary astrocytes following exposure to LPS, IFNγ,
and TNFα, the cell proliferation and apoptosis of the
astrocytes were evaluated via the detection of Ki-67 and
BrdU. Ki-67 is a common proliferative marker of phases
G1, S, G2, and M, and BrdU is a specific marker of in-
corporation in the S phase of cell division. Double labeling
revealed Ki-67- and BrdU-positive cells among the astro-
cytes of the controls but few among the astrocytes fol-
lowing exposure to the LPS, IFNγ, and TNFα treatment
(Fig. 5a, c). Cell counts indicated that the numbers of Ki-
67- and BrdU-positive astrocytes were decreased among
the astrocytes treated with LPS, IFNγ and TNFα com-
pared with the controls (Fig. 5b, d).
A flow cytometry assay was performed by Annexin V-PI
staining to indicate cell survival, apoptosis, and necrosis
among the astrocytes that were with the combination
of LPS, IFNγ, and TNFα. The results revealed that the
apoptotic proportions of astrocytes in both the early
and later stages of apoptosis were increased in the
groups exposed to LPS, IFNγ, and TNFα treatment
compared with the control (Fig. 5e, f ). The surviving
proportions of astrocytes subjected to LPS, IFNγ, and
TNFα treatment also decreased accordingly. The data
thus suggested that the decrease in the cell viability of
the astrocytes following the treatment with LPS, IFNγ,
and TNFα might have been attributable to both the in-
hibition of cell proliferation and apoptosis.
Knock-down of Gas1 rescued astrocyte viability via the
inhibition of Bax expression, the activation of cleaved
caspase-3, and cell apoptosis
To observe the implications of the Gas1 signal in the in-
hibition of the proliferation and apoptosis of the reactive
astrocytes treated with LPS, IFNγ, and TNFα, Gas1
knockdown and biological effect experiments were per-
formed. Cultured astrocytes were transfected with three
designed Gas1 siRNAs, and the total RNA was isolated for
real-time PCR analysis at 48 h. The results revealed that
the siGas1-3 effectively down-regulated Gas1 expression
Fig. 3 Expression of Gas1 in primary astrocytes and influence of LPS on cell viability of astrocytes. a Immunoblots of Gas1 expression and cleaved
caspase-3 in the astrocytes with increasing culture times of 24, 48, 72, and 96 h. b Immunoblots of Gas1 expression levels in the astrocytes with
increasing cell density from the cerebral cortex and substantia nigra. c Cell viability of the astrocytes with LPS insult at increasing concentrations
of 0.1, 0.5, 1, 5, 10, and 20 μg/ml. d Cell viability of the astrocytes under control and LPS (1 μg/ml) insult with increasing times of 24, 48, 72,
and 96 h
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in the astrocytes compared with the scrambled siRNA
control (Fig. 6a). siGas1-3 was selected for the biological
effect analysis of Gas1 knockdown. Western blotting con-
firmed that the knockdown or decrease in Gas1 protein
expression was sustained for at least 72 h (Fig. 6b).
To study the influence of Gas1 gene knockdown on
cell apoptosis among the reactive astrocytes caused by
exposure to LPS, IFNγ, and TNFα, a CCK-8 assay, LDH
release, flow cytometry assay, TUNEL staining, and
GAFP/Ki-67 and GFAP/BrdU double-labeling were per-
formed. The decrease in cell viability and the increase in
LDH release were significantly rescued when Gas1 ex-
pression was down-regulated in advance by the adminis-
tration of the siRNA (Fig. 6c, d). Flow cytometry and
TUNEL assays further revealed that the apoptosis of the
astrocytes caused by the LPS, IFNγ and TNFα treatment
could be inhibited by the knockdown of Gas1 expression
(Fig. 6e, f ). Intriguingly, however, the knockdown of
Gas1 did not obviously change the numbers of Ki-67-
or BrdU-positive astrocytes treated with LPS, IFNγ, and
TNFα (Fig. 6g).
Finally, a potential mechanism underlying the Gas1-
induced apoptosis was observed in reactive astrocytes
following inflammatory treatment with LPS, IFNγ, and
TNFα. The knock-down effects of Gas1 siRNA on Gas1
expression were examined in relation to changes in
apoptosis-related signaling molecules, such as Bax, Bcl-2,
and cleaved caspase-3, in the astrocytes. Western blotting
revealed that Gas1 siRNA effectively decreased the Bax
expression and the cleaved caspase-3 level, but it did not
significantly alter the Bcl-2 or p-NFkB-p65 levels in the
astrocytes that were treated with LPS, IFNγ and TNFα
Fig. 4 Influence of LPS, IFNγ, TNFα, and their combinations on expression of Gas1 and iNOS, cell viability, and cell death, and generation of
reactive oxygen species (ROS) in cell culture of astrocytes. a Gas1-immunoreactivity in astrocytes after treatment with LPS, IFNγ, and TNFα.
b Immunoblots of Gas1 and iNOS in the astrocytes with distinct treatments at 24 h. c Comparison of Gas1 and iNOS levels among above
groups. d Cell viability determined by CCK-8 assay. e Cell death determined by LDH release assay. f ROS generation assay in above distinct
groups of astrocytes. ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001 vs control (mean ± S.E.M., n = 3)
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(Fig. 7a–c). These data together suggested that the up-
regulated Gas1 signal might have induced apoptosis
among the reactive astrocytes by increasing the Bax/
Bcl-2 ratio, enhancing ROS generation, and triggering
the activation of the caspase-3-dependent signaling path-
way during neuroinflammatory events (Fig. 8).
Discussion
In this study, we investigated the expression profile and
dynamic changes in Gas1 in the brains of LPS and MPTP
models and presented the new finding that Gas1 expres-
sion was dramatically induced in reactive astrocytes in the
substantia nigra. The knockdown of Gas1 gene expression
in the primary astrocytes further confirmed that the in-
duction of Gas1 expression in these activated astrocytes
accelerated the elimination of these cells via Bax/caspase-
dependent apoptosis. The data from this study together
suggest a pivotal regulatory role of Gas1 in the apoptosis
of reactive astrocytes or astrogliosis in the injured sub-
stantia nigra regions of PD models.
Reactive astrogliosis is well established to be actively
involved in the entire pathological process of the PD
condition. However, whether astrogliosis plays a benefi-
cial or harmful role remains to be established [27, 28].
Although neurotrophic factors, such as glial-derived
neurotrophic factor (GDNF), basic fibroblast growth fac-
tor, and brain-derived neurotrophic factor (BDNF), have
been identified in these activated astrocytes [25, 29], a
line of growing evidence has demonstrated that LPS or
inflammatory factors also trigger astrocytes to release
the pro-inflammatory cytokines NO and ROS, which are
detrimental to the neighboring neurons [5, 30, 31]. Gen-
omic analysis of an LPS mouse model revealed that the
activated astrocytes exhibit a detrimental phenotype
[32]. Consistently, we observed significant increases in
the pro-inflammatory factors iNOS and ROS in the acti-
vated astrocytes following stimulation with LPS in com-
bination with other cytokines. Thus, the identification of
new regulators that control inflammatory astrogliosis
and the prevention of the progression of PD by the
Fig. 5 Influence of LPS, IFNγ, and TNFα on cell proliferation, survival, and apoptosis of primary astrocytes. a GFAP/Ki-67 double labeling in
astrocytes of control and LIT (LPS + IFNγ + TNFα) group. b Comparison of Ki-67-positive cells per unit field between control and LIT group.
c GFAP/BrdU double labeling in astrocytes of control and LIT group. d Comparison of BrdU-positive cells per unit field between control and
LIT group. e, f Flow cytometry shows survival, necrosis and apoptosis of astrocytes of control and LIT group by Annexin V and PI staining. B1
necrotic cells; B2 late apoptotic cells; B3 viable cells; B4 early apoptosis. ANOVA, **P < 0.01 vs control (mean ± S.E.M., n = 3)
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elimination of these activated astrocytes with detrimen-
tal properties may be essential.
Gas1 is a pleiotropic protein that can inhibit cell
growth and induce apoptosis in cancer cells and actively
participates in mammalian embryonic development [33].
Gas1 expression has been widely found in the CNSs of
adult rodents, and Gas1 is abundantly localized in both
astrocytes and neurons [19]. While the biological impli-
cations of Gas1 in the mediation of neuronal apoptosis
have been demonstrated in functional studies of Gas1 in
SH-SY5Y cells and the hippocampus [15, 16], the poten-
tial role of Gas1 in astrocytes remains unclear. An inte-
resting finding of this study is that Gas1 up-regulation
was induced in reactive astrocytes and accompanied by
apoptosis in the injured nigras of the LPS rat model and
the MPTP mouse model of PD. Additionally, we also
identified the gradual up-regulation of Gas1 and GFAP
expression levels in the midbrain with the increasing
ages of the rats (data not shown). The increase in reactive
astrocytes is one of the most identified and accepted bio-
markers of brain aging [34] and might partially explain
the PD susceptibility of older populations. In astrocyte cell
cultures, Gas1 expression is also remarkably increased
following the administration of the combination of LPS,
IFNγ, and TNFα. The expression trend of Gas1 was par-
tially consistent with the iNOS and ROS levels, which
suggests that the increases in iNOS and ROS might
possibly contribute to the Gas1-induced apoptosis of
reactive astrocytes following exposure to inflammatory
cytokines, which was most obvious following stimula-
tion with the combination of LPS, IFNγ, and TNFα.
Accumulating evidence has demonstrated the over-
activation-induced cell death of astrocytes in vivo and
in vitro. LPS-induced systemic inflammation can increase
Fig. 6 Effect of siRNA knockdown of Gas1 expression on survival, apoptosis, and proliferation of the primary astrocytes. a siRNA knockdown efficiency
of three small interfering RNA specific towards Gas1 (siGas1) determined by real time qPCR. *P < 0.05, ***P < 0.001 vs control (mean ± S.E.M., n = 3).
b Effective working time of siGas1 measured by immunoblot. c, d Influence of down-regulated Gas1 on cell viability or necrotic death of astrocytes
of control and treated with LPS, IFNγ and TNFα by CCK-8 and LDH assay. ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001 vs control, n.s. no significance
(mean ± S.E.M., n = 3). e Influence of down-regulated Gas1 on survival, apoptosis, and necrosis of primary astrocytes by flow cytometry. f Influence
of Gas1 siRNA on apoptosis of cultured astrocytes treated with LPS, IFNγ, and TNFα by TUNEL staining. g Influence of Gas1 siRNA on proliferation
state of astrocytes treated with LPS, IFNγ, and TNFα by Ki-67/BrdU double labeling
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Fig. 8 A schematic showing of Gas1 functional ways in mediating apoptosis of reactive astrocytes, in which up-regulation of inducible
Gas1 signaling might be resulted from inflammatory NFkB activation, and then possibly participate in increasing reactive oxygen species
(ROS) or oxidative stress, enhancing Bax/Bcl-2 ratios, and finally triggering caspase-3 activation-related apoptosis of reactive astrocytes in
LPS and MPTP models or inflammatory events
Fig. 7 Influence of siRNA on Gas1 knockdown, Bax, Bcl-2, p-NFkB-p65, and cleaved caspase-3 levels in primary astrocytes treated with LPS, IFNγ, and
TNFα. a Immunoblots of Gas1, Bax, Bcl-2, p-NFkB-p65, and cleaved caspase-3 in siNC and siGas1 group. b Comparison of Bax/Bcl-2 ratios between
siNC and siGas1 group. c Comparison of p-NFkB-p65 and cleaved-caspase-3 levels between siNC and siGas1 group. ANOVA, **P < 0.01 vs siNC group
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iNOS and the activations of both astrocytes and microglial
cells in the hippocampus and midbrain, and these acti-
vations are paralleled by the time-dependent apoptosis
of astrocytes and microglia [35]. The apoptosis of astro-
cytes has also been observed in the brains of Alzheimer’s
disease [7] and HIV encephalitis [8] patients. Nitric oxide
(NO) produced in vitro by activated astrocytes has been
found to not only damage surrounding neurons but also
induce the apoptosis of astrocytes in a caspase-dependent
manner [10, 36]. Our results indicated that the stereotactic
injection of LPS also induced significant apoptosis among
activated astrocytes in the injured nigras. However, LPS
in vitro alone did not exhibit an effect on the viability
of primary astrocytes at different concentrations and
treatment periods. One possible explanation is that the
relative lack of TLR4 in astrocytes mediated the LPS
effect compared with the TLR4 signaling of the micro-
glial cells [4, 37]. Astrocytes were recently reported to
indirectly respond to LPS through the release of soluble
mediators from the surrounding microglia [38], neu-
rons, or other immune cells. Among these soluble
mediators, TNFα and IFNγ are the two major pro-
inflammatory factors, and the TNFα and IFNγ recep-
tors are remarkably up-regulated in activated astrocytes
[39, 40]. Consistently, LPS, TNFα, or IFNγ alone were
unable to induce astrocyte death, but the combination
of LPS, TNFα, and IFNγ decreased the viability of the
primary astrocytes, and this decrease was paralleled by
increased iNOS and ROS levels. Some authors have
attributed the death of astrocytes to NO toxicity due
to autocrine release, and the administration of N-
monomethyl L-arginine, an inhibitor of iNOS, can
partially block the cell death of activated astrocytes
[10, 36, 41]. Additionally, the present study also pro-
vided evidence that the decrease in astrocyte viability
might also be partially the result of the inhibition of
proliferation caused by LPS, TNFα, or IFNγ stimulation.
Moreover, Gas1/TH double immunofluorescence stai-
ning was also performed in the LPS and MPTP animal
models. Clearly, Gas1-immunoreactivity was also detected
in the cytoplasm and nuclei of the nigral neurons, and
nearly all TH-positive neurons, exhibited Gas1 positivity.
We also confirmed the gradual elevation of Gas1 expres-
sion in the SH-SY5Y dopaminergic cells that was accom-
panied by apoptosis in a serum-deprived condition [15].
Gas1 knockdown increases the protective effect of GDNF
against glutamate-induced injury in SH-SY5Y cells [23],
and Gas1 has been reported to be induced and involved
in the excitotoxic deaths of hippocampal neurons [16].
Thus, the data from the present study may also propose a
critical question regarding the enrollment of the up-
regulation of the Gas1 signal in the mediation of the
apoptosis of dopaminergic neurons in the substantia nigra
during the pathogenesis of PD.
Finally, we confirmed relationship between the Gas1
expression level and the cell viability of the activated as-
trocytes via a siRNA knock-down experiment. The results
of this experiment indicated that the knock-down of Gas1
rescued the cell viability of the astrocytes via the inhibition
of apoptosis. Gas1 is a well-known growth arrest protein
that has been proven to block the transition of the G0 to
the S phase in fibroblasts [42], glioblastomas [43], and
breast cancer cells [44]. As a pleiotropic protein, Gas1
appears to exert multiple functional roles in distinct cell
types. The intracellular signaling analysis of the present
study revealed that the potential underlying mechanism of
astrocyte apoptosis induced by LPS, TNFα, and IFNγ
treatment was evidently related to the up-regulation of
Bax, which is a pro-apoptotic protein that follows the acti-
vation of caspase-3. The knock-down of Gas1 was con-
firmed to decrease the Bax/Bcl-2 ratio, alleviate caspase-3
activation, and ultimately diminish the apoptosis of reac-
tive astrocytes. This point is supported by the previous
clue regarding Gas1-induced cell apoptosis due to the Bax/
Bcl-2 ratio and caspase-3 activation in gastric cancer [14].
Nevertheless, this work should merit further investigations
of the precise functions of Gas1 in the regulation of
astrogliosis, astrocyte survival, and apoptosis to further
understand the inflammatory responses and pathological
progression of PD in human beings.
Conclusions
This study identified Gas1 as a novel modulator in apop-
tosis in reactive astrocytes via in vivo and in vitro experi-
ments. The up-regulation of Gas1 expression was inducible
in reactive astrocytes in the injured nigras of LPS and
MPTP models and was correlated with the apoptosis of
these reactive astrocytes. While the up-regulation of Gas1
was able to induce apoptosis and the inhibition of the pro-
liferation of astrocytes following exposure to LPS, IFNγ,
and TNFα, the knockdown of Gas1 exhibited a rescuing
effect on the astrocytes via modulations of the Bax/Bcl-2
ratio and cleaved caspase-3 activation and apoptosis.
Taken together, these results indicate that the Gas1 signal
may work as new regulator of cell survival and apoptosis
of reactive astrocytes. The potential underlying mecha-
nisms are illustrated schematically in Fig. 8. Hopefully,
further studies of the functions of Gas1 related to the
regulation of astrogliosis, astrocyte survival, and apoptosis
will benefit the understanding of the inflammatory res-
ponse and the establishment of a novel intervention
against inflammatory injury in PD conditions.
Additional files
Additional file 1: Figure S1. Gas1/GFAP and Gas1/TH double labeling
shows localization of Gas1 in both astrocytes and neurons in the substantia
nigra of LPS and MPTP model by each fluorescence channel images. A-A”,
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Gas1 single, GFAP single, and Gas1/GFAP merged images in the nigral
astrocytes of LPS rat model-3w; B-B”, Gas1 single, TH single, and Gas1/
TH merged images in nigral dopaminergic neurons of MPTP mouse
model-3w. (TIF 2545 kb)
Additional file 2: Figure S2. (A) Western blotting verification of Gas1
expression (H-300 antibody) and cleaved caspase-3 in SH-SY5Y cells
under serum-deprived state with increasing culture times; (B) Comparison
of Gas1 and cleaved caspase-3 levels in SH-SY5Y cells among distinct culture
time-points of 0, 24, 48, 72 and 96 h; (C, D) Influence of LPS, IFNγ and TNFα
on cell viability of primary astrocytes isolated from the substantia nigra and
striatum. ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001 vs control (mean ± S.E.M.,
n = 3). (TIF 2777 kb)
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